# The Effect of Milnacipran in Patients With Fibromyalgia

> **NCT01108731** · PHASE2,PHASE3 · COMPLETED · sponsor: **Beth Israel Medical Center** · enrollment: 37 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Milnacipran
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01108731
- **Lead sponsor:** Beth Israel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01108731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01108731, "The Effect of Milnacipran in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01108731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*